Article info

Download PDFPDF
Oral antiviral treatment in patients with systemic rheumatic disease at risk for development of severe COVID-19: a case series

Authors

  • George E Fragoulis Joint Rheumatology Program, First Department of Internal Medicine, Propedeutic Clinic, “Laiko” hospital, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Christos Koutsianas Joint Rheumatology Program, Second Department of Internal Medicine, “Hippokration” Hospital, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Kalliopi Fragiadaki Joint Rheumatology Program, First Department of Internal Medicine, Propedeutic Clinic, “Laiko” hospital, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Ilias Mariolis Joint Rheumatology Program, Second Department of Internal Medicine, “Hippokration” Hospital, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Stylianos Panopoulos Joint Rheumatology Program, First Department of Internal Medicine, Propedeutic Clinic, “Laiko” hospital, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Christina Tsalapaki Joint Rheumatology Program, Second Department of Internal Medicine, “Hippokration” Hospital, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Maria Pappa Joint Rheumatology Program, First Department of Internal Medicine, Propedeutic Clinic, “Laiko” hospital, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Theodoros Dimitroulas Fourth Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece PubMed articlesGoogle scholar articles
  • Maria G Tektonidou Joint Rheumatology Program, First Department of Internal Medicine, Propedeutic Clinic, “Laiko” hospital, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Dimitrios Vassilopoulos Joint Rheumatology Program, Second Department of Internal Medicine, “Hippokration” Hospital, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Petros P Sfikakis Joint Rheumatology Program, First Department of Internal Medicine, Propedeutic Clinic, “Laiko” hospital, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  1. Correspondence to Dr George E Fragoulis, Joint Rheumatology program, First Department of Internal Medicine, Propedeutic clinic, “Laiko” hospital, National and Kapodistrian University of Athens, Athens, Greece; geofragoul{at}yahoo.gr
View Full Text

Citation

Fragoulis GE, Koutsianas C, Fragiadaki K, et al
Oral antiviral treatment in patients with systemic rheumatic disease at risk for development of severe COVID-19: a case series

Publication history

  • Received May 25, 2022
  • Accepted May 31, 2022
  • First published June 14, 2022.
Online issue publication 
September 12, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.